FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel E. Lynch, president and CEO, will provide an update of corporate activities at the BIO CEO and Investor Conference on Monday, February 11 at 2:45 p.m. Eastern Time. The presentation is being held in the West Foyer at the Waldorf Astoria in New York City.
